- Home
- PHAR vs HLX Comparison
PHAR vs HLX Comparison
Compare PHAR & HLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- HLX
- Stock Information
- Founded
- PHAR 1988
- HLX 1979
- Country
- PHAR Netherlands
- HLX United States
- Employees
- PHAR N/A
- HLX N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- HLX Oilfield Services/Equipment
- Sector
- PHAR Health Care
- HLX Energy
- Exchange
- PHAR Nasdaq
- HLX Nasdaq
- Market Cap
- PHAR 951.7M
- HLX 928.9M
- IPO Year
- PHAR N/A
- HLX 1997
- Fundamental
- Price
- PHAR $13.18
- HLX $6.64
- Analyst Decision
- PHAR Strong Buy
- HLX Strong Buy
- Analyst Count
- PHAR 3
- HLX 2
- Target Price
- PHAR $30.00
- HLX $10.50
- AVG Volume (30 Days)
- PHAR 9.7K
- HLX 1.6M
- Earning Date
- PHAR 11-06-2025
- HLX 10-22-2025
- Dividend Yield
- PHAR N/A
- HLX N/A
- EPS Growth
- PHAR N/A
- HLX 497.36
- EPS
- PHAR N/A
- HLX 0.28
- Revenue
- PHAR $339,836,000.00
- HLX $1,312,445,000.00
- Revenue This Year
- PHAR $17.70
- HLX N/A
- Revenue Next Year
- PHAR $12.25
- HLX $4.96
- P/E Ratio
- PHAR N/A
- HLX $23.51
- Revenue Growth
- PHAR 22.44
- HLX N/A
- 52 Week Low
- PHAR $7.31
- HLX $5.52
- 52 Week High
- PHAR $17.08
- HLX $11.48
- Technical
- Relative Strength Index (RSI)
- PHAR 43.85
- HLX 50.93
- Support Level
- PHAR $13.03
- HLX $6.60
- Resistance Level
- PHAR $13.43
- HLX $6.97
- Average True Range (ATR)
- PHAR 0.49
- HLX 0.29
- MACD
- PHAR -0.10
- HLX -0.00
- Stochastic Oscillator
- PHAR 23.47
- HLX 26.55
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About HLX Helix Energy Solutions Group Inc.
Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.